|
TMEM194B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18558504627708E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-16 |
| Normal-vs-Stage2 |
1.699490E-03 |
| Normal-vs-Stage3 |
5.795800E-04 |
| Normal-vs-Stage4 |
1.258190E-02 |
| Stage1-vs-Stage2 |
1.330570E-01 |
| Stage1-vs-Stage3 |
1.031800E-04 |
| Stage1-vs-Stage4 |
5.434800E-04 |
| Stage2-vs-Stage3 |
3.121400E-01 |
| Stage2-vs-Stage4 |
2.201600E-01 |
| Stage3-vs-Stage4 |
7.288600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83630888273001E-13 |
| Normal-vs-AfricanAmerican |
3.720300E-02 |
| Normal-vs-Asian |
6.295500E-02 |
| Caucasian-vs-AfricanAmerican |
7.444500E-03 |
| Caucasian-vs-Asian |
8.453400E-01 |
| AfricanAmerican-vs-Asian |
1.996430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55099996682162E-09 |
| Normal-vs-Female |
1.03249631067115E-11 |
| Male-vs-Female |
5.722800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.179700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.4265038563226E-11 |
| Normal-vs-Age(61-80Yrs) |
3.8349001751925E-10 |
| Normal-vs-Age(81-100Yrs) |
3.404300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.274190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.685790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.716400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.951200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.308600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.029400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.34859999945114E-07 |
| Normal-vs-Grade 2 |
4.44089209850063E-16 |
| Normal-vs-Grade 3 |
1.23409999996937E-07 |
| Normal-vs-Grade 4 |
2.260400E-01 |
| Grade 1-vs-Grade 2 |
7.823600E-01 |
| Grade 1-vs-Grade 3 |
1.587990E-01 |
| Grade 1-vs-Grade 4 |
6.280700E-03 |
| Grade 2-vs-Grade 3 |
1.376020E-03 |
| Grade 2-vs-Grade 4 |
3.39980000041429E-07 |
| Grade 3-vs-Grade 4 |
1.007970E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
5.576400E-03 |
| ccA subtype-vs-ccB subtype |
2.22333262911434E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.49430525917683E-11 |
| Normal-vs-N1 |
5.631200E-01 |
| N0-vs-N1 |
9.992100E-02 |
|
|
